Stryker Co. (NYSE:SYK) Shares Sold by Steigerwald Gordon & Koch Inc.

Steigerwald Gordon & Koch Inc. cut its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 1.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 68,349 shares of the medical technology company's stock after selling 933 shares during the period. Stryker comprises approximately 2.8% of Steigerwald Gordon & Koch Inc.'s investment portfolio, making the stock its 8th biggest position. Steigerwald Gordon & Koch Inc.'s holdings in Stryker were worth $25,443,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Kohmann Bosshard Financial Services LLC bought a new stake in Stryker during the fourth quarter worth $25,000. Capital A Wealth Management LLC acquired a new position in shares of Stryker during the fourth quarter worth $26,000. Rakuten Securities Inc. increased its holdings in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after buying an additional 68 shares in the last quarter. Centricity Wealth Management LLC acquired a new position in shares of Stryker during the fourth quarter worth $30,000. Finally, BankPlus Trust Department acquired a new position in shares of Stryker during the fourth quarter worth $33,000. 77.09% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Barclays upped their price target on shares of Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Roth Mkm upped their price target on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Wall Street Zen downgraded Stryker from a "buy" rating to a "hold" rating in a report on Thursday, March 6th. Finally, Truist Financial increased their price objective on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, Stryker presently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Trading Up 0.0%

SYK traded up $0.19 during trading on Thursday, reaching $382.74. 904,802 shares of the stock traded hands, compared to its average volume of 1,332,627. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $146.09 billion, a PE ratio of 49.32, a P/E/G ratio of 2.93 and a beta of 0.93. The stock's 50-day moving average is $369.68 and its 200 day moving average is $376.11. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The business's revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.50 EPS. Equities analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 5.90% of the company's stock.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.